The Signal

CME Group and ICE are actively pushing the CFTC to scrutinize Hyperliquid’s onchain perpetuals—framing it as a market-structure and price-discovery threat that’s starting to bleed into “real” commodity benchmarks, not just crypto. [MSN, The Block]

For prediction markets, the significance is directional: incumbent, regulated exchanges are now using the same playbook they’ve used against offshore venues in other derivatives—ask the CFTC to re-draw the line between “event-style” onchain contracts and regulated futures/swaps—then enforce distribution choke points. That enforcement posture inevitably spills into how the CFTC thinks about event contracts (Kalshi/CME event products) vs offshore/crypto event venues (Polymarket and peers), because it’s the same core question: what counts as a U.S.-accessible derivatives market, and what surveillance/identity standards come with that?

Hyperliquid’s response—via its Policy Center—is to argue that onchain transparency is better surveillance and that self-custody can coexist with compliant oversight. [The Block]

The Mechanism

• Incumbents are trying to convert “competition” into a jurisdictional issue. CME/ICE can’t out-ship onchain UX quickly, so they’re leaning on a regulator to make where the liquidity lives a compliance decision.

• The CFTC pressure point is distribution, not ideology. Even if Hyperliquid is offshore or “decentralized,” the practical lever is U.S. access: brokers, FCMs, payment rails, front ends, and any U.S.-tied intermediaries. That’s the same basic enforcement geometry that would matter for event venues too.

• This accelerates the bifurcation we’ve been tracking: surveilled/onshore vs viral/offshore. IBKR’s new multi-venue hub (Kalshi/CME/ForecastEx) makes the regulated stack easier to buy. [MSN] Meanwhile, mainstream media is teeing up “integrity” narratives around offshore prediction flow (the Polymarket war-bets story). The combined effect is to make institutional distribution feel safer onshore.

• Expect “price discovery” to become the key rhetorical weapon against offshore liquidity. Once incumbents claim offshore venues are influencing reference prices (oil, rates, etc.), regulators get a non-gambling rationale to act. Prediction markets are susceptible to the same framing if contracts are portrayed as affecting decision-making or benchmarks.

• Hyperliquid’s counter—“everything is auditable onchain”—isn’t enough without identity. Auditability helps after-the-fact investigations; regulated markets care about participant controls upfront (KYC/AML, position limits, market surveillance, and enforceable bans). That gap is exactly what regulated prediction venues pitch as their differentiator versus Polymarket-style stacks.

• Second-order effect: more scrutiny of “event-like perps.” If the CFTC tightens its posture on onchain derivatives broadly, it raises the perceived risk premium for any crypto-native event contract that resembles a swap/perp economically—even if it’s marketed as “prediction.”

The Landscape

Market Position

CME and ICE are signaling that onchain derivatives venues are no longer “crypto niche” competitors—they’re competing for mindshare in the same macro/commodities conversation that exchanges monetize. That matters for prediction markets because the industry is moving toward broker-distributed, multi-venue access (IBKR routing across Kalshi/CME/ForecastEx), which makes regulated venues feel like the default pipe for mainstream capital. When incumbents lobby successfully, it doesn’t just hit the target venue—it changes broker risk committees’ willingness to touch anything that smells like offshore event risk.

The competitive dynamic is becoming clearer: regulated venues are building distribution and compliance moats; offshore/onchain venues are building product velocity and global liquidity. The fight is increasingly decided at the regulator/broker layer rather than in UI.

Regulatory Environment

This CME/ICE push lands as Washington is already arguing about whether prediction markets should be curtailed—with the House reportedly holding off on an outright ban even amid bipartisan pressure. [NPR] At the same time, media focus on integrity issues (insider-trading-style allegations tied to Polymarket war contracts) is giving regulators a clean, investor-protection hook that doesn’t require debating “is this gambling?” [CBS]

Put together: the next phase of prediction market regulation is likely to be fought on market integrity and surveillance standards, not just on whether event contracts are permissible in principle.

Key Data

• CME + ICE escalation is being discussed in the context of CFTC oversight of Hyperliquid’s onchain perpetuals and alleged spillover into commodity price discovery. [The Block, MSN]
• Hyperliquid’s Policy Center (launched February) is the venue’s attempt to pre-negotiate a compliance narrative (“transparency as surveillance”) without giving up self-custody. [The Block]
• Interactive Brokers now distributes event contracts across Kalshi, CME, and ForecastEx in one interface, strengthening the onshore stack’s distribution advantage as offshore venues come under integrity scrutiny. [MSN]

What’s Next

Watch for the CFTC’s next public move to be procedural rather than dramatic: requests for information, staff advisories, or enforcement posture shifts that target U.S. access vectors (front ends, intermediaries, marketing, or broker connectivity) instead of trying to “ban a protocol.” If CME/ICE succeed in getting the CFTC to treat onchain perps as a systemic price-discovery issue, prediction markets should expect collateral pressure: higher expectations for KYC, surveillance tooling, and resolution governance—especially for any venue that wants broker distribution or institutional market making.

Predict This covers the evolution of prediction markets — platforms, regulation, volume, and methodology. For questions or tips: reply to this email.

🌐 Visit whatsthelatest.ai for the latest coverage and more.

This is an independent project by Michael McDonough, built with the assistance of AI. Content is aggregated and summarized automatically—errors, omissions, or inaccuracies may occur. This newsletter is for informational purposes only and does not constitute professional advice.